BioNanomatrix Announces Appointment of Paul R. Selvin to Its Scientific Advi...(nt and biological applications for the s...)

Date:4/30/2008

nt and biological applications for the study of the dynamics of biological macromolecules using fluorescence. He developed the FIONA imaging technique, which can deliver 1.5 nanometer spatial localization of single fluorescent molecules with 1-500 millisecond temporal resolution, an advance in precision over previous fluorescence imaging techniques. He has developed a number of single molecule fluorescence modifications for the FIONA system, as well as single molecule fluorescence resonance energy transfer. Previously, Dr. Selvin served as a scientist and researcher at the Lawrence Berkeley National Laboratory, the University of California, Berkeley, the University of Michigan and Coulter Biomedical Research Corporation.

"BioNanomatrix has distinctive nanoscale single molecule technology that has the potential to transform whole genome imaging and analysis, enabling researchers to conduct DNA analyses much faster and less expensively than with existing methods, while also achieving greater accuracy and retaining valuable contextual information," said Dr. Selvin. "I look forward to working with the BioNanomatrix team to contribute to the process of advancing the technical and commercial development of this promising new approach."

Dr. Selvin received a B.S. from the University of Michigan and a Ph.D. from the University of California, Berkeley. He was a postdoctoral fellow at the Lawrence Berkeley National Laboratory at the University of California, Berkeley. Dr. Selvin has authored over 70 publications and holds five patents.

About BioNanomatrix

BioNanomatrix is developing breakthrough nanoscale whole genome imaging and analytic platforms for applications in genetic diagnostics, personalized medicine and biomedical research applications. The company is applying its expertise in nanochips, nanodevices and nanosystems to develop its patented platform technology to provide fast, comprehensive, and low-cost analysis of genomic, epigenomic and
'/>"/>

SOURCE BioNanomatrix, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. BioNanomatrix Named Best Management Team at the 2008 Ben Franklin Emerging Business Awards
2. BioNanomatrix and Complete Genomics Receive $8.8 Million NIST-ATP Award to Develop Sequencing Platform for $100 Genome
3. BioNanomatrix Receives New NCI Grant to Support Development of Chip-Based Nanofluidics Systems for Cell Fractionation
4. BioNanomatrix Announces Issuance of Key Nanofluidics Patent Enabling Single Molecule Whole Genome Analysis
5. China Biologic Products Announces SFDA Approval for the Production of Cryoprecipitate and for the Clinical Trial of Human Prothrombin Complex
6. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
7. Beckman Coulter Announces First Quarter 2008 Results
8. Onyx Pharmaceuticals Announces First Quarter 2008 Financial Results Teleconference and Webcast
9. BioMarin Announces First Quarter 2008 Financial Results
10. Align Technology Announces $50 Million Stock Repurchase Program
11. Anesiva Announces New Zingo Marketing and Distribution Agreement